Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Developments in enzyme replacement therapy have kindled discussions on adding Pompe disease, characterized by progressive muscle weakness and wasting, to neonatal screening. Pompe disease does not fit traditional screening criteria as it is a broad-spectrum phenotype disorder that may occur in lethal form in early infancy or manifest in less severe forms from infancy to late adulthood. | Newborn screening for pompe disease? a qualitative study exploring professional views
